|
|
 Beijing KLR Medical & Consulting Co. Ltd (hereafter referred to as KLR) is an investigational product (IP) development support organization. KLR was established in Sep 2007 in Beijing, China, and consisted of industry and senior technical experts. It can provide full-service IP development, with a particular focus on regulatory affairs, clinical trial operations, quality controls and medical writing in the People’s Republic of China. KLR can provide services and expertise in the following areas: translation, medical writing, clinical trial operation, regulatory affairs, project third party audit, GCP training, medical consulting and other types of support. All the services above are carried out through our experienced and qualified team. We provide a “Scientific, Ethical, Honesty and Win-win” approach our clients with professional and efficient services. Our goal is to offer you the ability to put ideas into action to help to: l Improve regulatory compliance l Hedge risk and reduce infrastructure costs l Optimize your business processes l Make better portfolio decisions l Speeden clinical trials Since established, KLR has made commendable achievements relying on our core competitiveness, and has become a professional service provider for several well-known global pharmaceutical companies. Through a history of effective cooperation, KLR has built strong relationships with government authorities, famous clinical experts, medical research institutes and investigational sites. KLR believes that with the support of our clients and colleagues, KLR is able to deliver an effective, high quality clinical service. KLR is based in Beijing and Xuzhou in China, and welcomes clients from all over the world. |